Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Acetylsalicylic Acid
45%
Anticoagulation
39%
Antithrombotic
54%
Apoplexy
100%
Arterial Spin Labeling
15%
Autonomic Dysfunction
15%
Best Corrected Visual Acuity
22%
Brain Ischemia
52%
Bypass Surgery
33%
Carotid Artery Stenosis
21%
Central Retinal Artery Occlusion
30%
Cerebral Hemorrhage
54%
Diffusion MRI
20%
Dysautonomia
15%
Elderly Patient
15%
Extraintracranial Anastomosis
15%
Fluid Attenuated Inversion Recovery
26%
Gray Matter
19%
Hematoma
24%
Hemodynamic
53%
Infarction
22%
Limb
30%
Magnetic Resonance Imaging
36%
Meta-Analysis
15%
Morbidity
16%
National Institutes of Health Stroke Scale
23%
Noninferiority Trial
15%
Odds Ratio
19%
Oxygen 15
15%
Paroxysmal Atrial Fibrillation
15%
Patient-Data
15%
Perfusion Weighted Imaging
15%
Placebo
14%
Positron Emission Tomography
15%
Prospective Cohort Study
30%
Randomized Controlled Trial
21%
Recurrent Disease
15%
Revascularization
15%
Sex Differences
30%
Susceptibility Weighted Imaging
15%
Systematic Review
15%
Tenecteplase
30%
Thrombus
15%
Tissue Plasminogen Activator
15%
Transient Ischemic Attack
66%
Treatment Effect
15%
Vascular Disease
15%
Vertebral Artery
15%
Vertebral Artery Dissection
60%
Vitamin K Antagonist
20%
Keyphrases
6-month Follow-up
15%
95% Confidence Interval
17%
Acetazolamide
20%
Acute Ischemic Stroke
16%
Acute Stroke
15%
Anticoagulation
51%
Antithrombotic Therapy
27%
Aspirin
48%
Best-corrected Visual Acuity
22%
Bypass Patency
19%
Capital Region
16%
Central Retinal Artery Occlusion
30%
Cerebral Hemodynamics
35%
Cerebrovascular Hemodynamics
16%
Cervical Artery Dissection (CeAD)
60%
Clinical Significance
15%
Comorbidity
15%
Denmark
17%
EC-IC Bypass
17%
Extracranial-intracranial Bypass
18%
Fluid-attenuated Inversion Recovery (FLAIR)
15%
Hemodynamic Failure
22%
Hemodynamic Insufficiency
25%
Intracerebral Hemorrhage
60%
Ischemic Stroke
29%
Limb Shaking
37%
Long-term Stroke
15%
Modified Rankin Scale
33%
Moyamoya Disease
30%
Odds Ratio
16%
Oral Anticoagulants
60%
Perfusion
17%
Pivotal Trial
15%
Randomized Controlled Trial
22%
Randomized Trial
30%
Risk Factors
24%
Sex Differences
30%
Signal Intensity
15%
Stroke Ischemic
15%
Stroke Prevention
17%
Stroke Risk
15%
Subgroup Analysis
19%
Symptom Onset
18%
Tenecteplase
30%
Tissue Plasminogen Activator (t-PA)
15%
Transient Ischemic Attack
59%
Treatment Effect
15%
Trends in Incidence
15%
Ultrasound
15%
Vitamin K Antagonists
30%
